Dear Valued Provider

Effective April 1, 2018 Xtampza ER (oxycodone ER) will replace OxyContin as the preferred long-acting, abuse-deterrent oxycodone product. Participating Pharmacies will need to order these products to ensure access for Commercial Covered Persons.

Action Required

If Participating Pharmacies receive a prescription for OxyContin, the claim will reject with one the following reject messages:

1. If Oxycontin is excluded-Reject 70: NOT COVERED. USE XTAMPZA ER

2. If Oxycontin or another long-acting opiate is non-preferred-Reject 75: PA REQUIRED. CALL 1-800-352-2583

*Please see attached for more information*